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Graves' disease with functioning nodules is referred to as Marine-Lenhart Syndrome. Only 2.7% of
the patients with Graves’disease have concomitant functioning nodules.1 Thyroid scintigraphy often
definitively confirms the diagnosis. However, in addition to a hyperfunctioning (i.e. "hot") nodule,
the thyroid scan may reveal isofunctioning (i.e. "warm"), and or a nonfuntioning (i.e. "cold") nodule
as compared to the normal surrounding thyroid. Since hyperfuntioning nodules rarely harbor
malignancy, if one is found that corresponds to the nodule in question, no cytologic evaluation is
usually necessary.2 Conversely, the majority of all nonfunctioning nodules may be benign or less
frequently malignant, thus requiring cytopathologic evaluation.2 We report a patient with MarineLenhart syndrome with the dilemma of a “hot “nodule found on thyroid scintigraphy which had
“suspicious” ultrasonographic features prompting thyroidectomy after cytological diagnosis of
papillary thyroid cancer (PTC). In this case, the utilization of neck ultrasonography provided
significant risk stratifying data to support appropriate management.
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A 60-year-old female presented for evaluation of hyperthyroidism discovered by routine blood work.
She was asymptomatic and denied any thyroid-related symptoms of tremors, palpitations, weight
loss, heat intolerance, and hyperdefecation. However, she did exhibit mild anxiety and “jumpiness”
and her ophthalmological exam exhibited features of early Graves’ eye disease with conjunctival
injection and periorbital edema. Her labs confirmed mild hyperthyroidism with an undetectable TSH
of <0.01, free T4 2.01 (normal 0.82-1.77 ng/dL), free T3 6.8 (normal 2.0-4.4 pg/mL), TPO antibody
9 (normal 0-34 IU/mL), and TSI 352% (normal 0-139%) indicative of Graves' hyperthyroidism. She
denied a history of head and neck radiation and family history of thyroid disease. Subsequent
radionuclide I-123 labeled scan demonstrated a 24-hour thyroid uptake value of 35.8% (normal range
10-35%). Scintigraphic images revealed a mildly enlarged heterogenous thyroid with a cold nodule
in the right lower pole and a hot nodule in the left upper pole. Given the associated risk of cold
nodules harboring a malignant lesion, an ultrasound guided fine needle aspiration biopsy of the cold
nodule was pursued. Ultrasonography revealed a heterogeneous thyroid with bilateral nodules.
Within the right lobe, the largest nodule was 2.1 x 1.4 x 1.8 cm and was described as cystic with
septations containing mixed solid, cystic, and colloid components, with benign sonographic features
correlating with the cold nodule on the nuclear scan. The left lobe demonstrated a highly suspicious
1.3 x 1.3 x 1.2 cm upper pole nodule described as solid, irregular in contour with coarse
calcifications correlating with the hot nodule on the nuclear scan. Subsequently, fine needle
aspiration biopsies of these two nodules were done. The cytology of the right lower pole “cold”
nodule consisted of follicular, hurthle cells, macrophages, and abundant colloid consistent with
benign follicular nodule. Cytologic features of the left upper pole “hot” nodule was consistent with
PTC and molecular analysis revealed BRAF V600E mutation. She was started on Methimazole 10
mg daily in preparation for total thyroidectomy. After achieving a euthyroid state, she underwent an
uneventful total thyroidectomy. The left thyroid lobe demonstrated a 0.9 x 0.9 x 0.7 cm partially
encapsulated papillary thyroid carcinoma with perineural invasion, microscopic extrathyroidal
extension, but without capsular, lymphatic, or vascular invasion corresponding to the “hot” nodule on
scan. The right thyroid lobe demonstrated incidental multifocal micropapillary thyroid carcinomata
of 0.3 cm and 0.2 cm. There was a benign right lobe 2 cm adenomatoid nodule corresponding to the
“cold” nodule on nuclear scan. The Final AJCC-TMN classification was pT3N0Mx.
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Graves' disease may harbor an increased
incidence of thyroid carcinomas.3 Thyroid
imaging modalities have evolved over the last
several decades to assist clinicians with the
diagnosis of thyroid disease. Thyroid
scintigraphy assesses thyroid functionality by
characterizing the anatomical distribution and
intensity of radioactive tracer uptake. Neck
ultrasonography provides descriptive
morphologic features which may greatly
contribute to risk stratification of thyroid
malignancy. Current literature suggests that
hyperfuntioning nodules rarely harbor
malignancy and therefore no cytologic
evaluation is necessary. However, in patients
with coexistent thyroid nodules and Graves'
disease, thyroid ultrasonography may shed
light on characteristics suggestive of thyroid
malignancy, thus allowing for proper
therapeutic intervention as in our case where
thyroid ultrasonography pinpointed the final
pathology of PTC.
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